Literature DB >> 21787672

Zearalenone activates pregnane X receptor, constitutive androstane receptor and aryl hydrocarbon receptor and corresponding phase I target genes mRNA in primary cultures of human hepatocytes.

Imen Ayed-Boussema1, Jean Marc Pascussi, Patrick Maurel, Hassen Bacha, Wafa Hassen.   

Abstract

The mycotoxin zearalenone (ZEN) is found worldwide as a contaminant in cereals and grains. ZEN subchronic and chronic toxicities are dominated by reproductive disorders in different mammalian species which have made ZEN established mammalian endocrine disrupter. Over the last 30 years of ZEN biotransformation study, the toxin was thought to undergo reductive metabolism only, with the generation in several species of α- and β-isomers of zearalenol. However, recent investigations have noticed that the mycoestrogen is prone to oxidative metabolism leading to hydroxylation of ZEN though the involvement of different cytochromes P450 (CYPs) isoforms. The aim of the present study was to further explore the effect of ZEN on regulation of some CYPs using primary cultures of human hepatocytes. For this aim, using real time RT-PCR, we monitored in a first time, the effect of ZEN on mRNA levels of pregnane X receptor (PXR), constitutive androstane receptor (CAR) and aryl hydrocarbon receptor (AhR), nuclear receptors known to be involved in the regulation of some CYPs. In a second time, we looked for ZEN effect on expression of PXR, CAR and AhR corresponding phase I target genes (CYP3A4, CYP3A5, CYP2B6, CYP2C9, CYP1A1 and CYP1A2). Finally, we realised the luciferase assay in HepG2 treated with the toxin and transiently transfected with p-CYP3A4-Luc in the presence of a hPXR vector or transfected with p-CYPA1-Luc.Our results clearly showed that ZEN activated human PXR, CAR and AhR mRNA levels in addition to some of their phase I target genes mainly CYP3A4, CYP2B6 and CYP1A1 and at lesser extent CYP3A5 and CYP2C9 at ZEN concentrations as low as 0.1 μM.
Copyright © 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21787672     DOI: 10.1016/j.etap.2010.09.008

Source DB:  PubMed          Journal:  Environ Toxicol Pharmacol        ISSN: 1382-6689            Impact factor:   4.860


  16 in total

1.  Assessment of genotoxicity associated with Behcet's disease using sister-chromatid exchange assay: vitamin E versus mitomycin C.

Authors:  Omar F Khabour; Khaldon Alawneh; Etizaz Al-Kofahi; Fahmee Mesmar
Journal:  Cytotechnology       Date:  2014-05-23       Impact factor: 2.058

Review 2.  Mycotoxins: cytotoxicity and biotransformation in animal cells.

Authors:  Jikai Wen; Peiqiang Mu; Yiqun Deng
Journal:  Toxicol Res (Camb)       Date:  2016-01-07       Impact factor: 3.524

3.  Toxic effects of maternal zearalenone exposure on uterine capacity and fetal development in gestation rats.

Authors:  Yuanyuan Zhang; Zhiqiang Jia; Shutong Yin; Anshan Shan; Rui Gao; Zhe Qu; Min Liu; Shaoping Nie
Journal:  Reprod Sci       Date:  2013-12-19       Impact factor: 3.060

4.  Effects of adrenolytic mitotane on drug elimination pathways assessed in vitro.

Authors:  Dirk Theile; Walter Emil Haefeli; Johanna Weiss
Journal:  Endocrine       Date:  2014-12-27       Impact factor: 3.633

Review 5.  Research Progress of Safety of Zearalenone: A Review.

Authors:  Xiao Han; Bingxin Huangfu; Tongxiao Xu; Wentao Xu; Charles Asakiya; Kunlun Huang; Xiaoyun He
Journal:  Toxins (Basel)       Date:  2022-06-02       Impact factor: 5.075

6.  The novel antibacterial compound walrycin A induces human PXR transcriptional activity.

Authors:  Alexandre Berthier; Frédérik Oger; Céline Gheeraert; Abdel Boulahtouf; Rémy Le Guével; Patrick Balaguer; Bart Staels; Gilles Salbert; Philippe Lefebvre
Journal:  Toxicol Sci       Date:  2012-02-07       Impact factor: 4.109

7.  Polymorphisms in CYP1B1, CYP3A5, GSTT1, and SULT1A1 Are Associated with Early Age Acute Leukemia.

Authors:  Bruno Almeida Lopes; Mariana Emerenciano; Bruno Alves Aguiar Gonçalves; Tállita Meciany Vieira; Ana Rossini; Maria S Pombo-de-Oliveira
Journal:  PLoS One       Date:  2015-05-18       Impact factor: 3.240

8.  Interaction potential of the multitargeted receptor tyrosine kinase inhibitor dovitinib with drug transporters and drug metabolising enzymes assessed in vitro.

Authors:  Johanna Weiss; Dirk Theile; Zdenek Dvorak; Walter Emil Haefeli
Journal:  Pharmaceutics       Date:  2014-12-16       Impact factor: 6.321

9.  Venetoclax (ABT-199) Might Act as a Perpetrator in Pharmacokinetic Drug-Drug Interactions.

Authors:  Johanna Weiss; Thomas Gajek; Bruno Christian Köhler; Walter Emil Haefeli
Journal:  Pharmaceutics       Date:  2016-02-24       Impact factor: 6.321

Review 10.  Fusarium Molds and Mycotoxins: Potential Species-Specific Effects.

Authors:  Alessia Bertero; Antonio Moretti; Leon J Spicer; Francesca Caloni
Journal:  Toxins (Basel)       Date:  2018-06-15       Impact factor: 4.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.